Radiance Therapeutics

Oro Valley, United States Founded: 2018 • Age: 8 yrs
Beta ophthalmic applicator for glaucoma surgery is developed.
Annual revenue - Latest available
Total funding $14.0M 3 rounds
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 5 Brand Intelligence

About Radiance Therapeutics

Radiance Therapeutics is a company based in Oro Valley (United States) founded in 2018. Radiance Therapeutics has raised $14 million across 3 funding rounds. Radiance Therapeutics operates in a competitive market with competitors including ViaLase, BELKIN Vision, ELIOS Vision and EyeLight, among others.

  • Headquarter Oro Valley, United States
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Radiance Therapeutics, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $14 M (USD)

    in 3 rounds

  • Latest Funding Round
    $4.29 M (USD), Series B

    Jan 20, 2022

  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

People of Radiance Therapeutics

Headcount 10-50
Employee Profiles 2
Employee Profiles
People
G. Todd Silva
Interim CEO & Chief Financial Officer

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of Radiance Therapeutics

Radiance Therapeutics has successfully raised a total of $14M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $4.29 million completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investments & Acquisitions by Radiance Therapeutics

Investments
Premium access

Investment portfolio details for Radiance Therapeutics

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Radiance Therapeutics

Premium access

Detailed financials for Radiance Therapeutics

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Radiance Therapeutics Comparisons

Radiance Therapeutics Primary company
Description
Beta ophthalmic applicator for glaucoma surgery is developed...
Location
Oro Valley, United States
Founded Year
2018
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Radiance Therapeutics

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Radiance Therapeutics

Radiance Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ViaLase, BELKIN Vision, ELIOS Vision and EyeLight, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Image-guided femtosecond laser devices for glaucoma treatments are developed.
Locked Locked Locked
Laser device for glaucoma treatment developed by BELKIN Vision.
Locked Locked Locked
Excimer laser technology is applied to develop glaucoma therapy devices.
Locked Locked Locked
Develops patented treatment methods for glaucoma.
Premium access

Detailed competitors of Radiance Therapeutics

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Radiance Therapeutics

Premium access

Complete news archive for Radiance Therapeutics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Radiance Therapeutics

Radiance Therapeutics was founded in 2018 and raised its 1st funding round 1 year after it was founded.

Radiance Therapeutics is headquartered in Oro Valley, United States. It is registered at Oro Valley, Arizona, United States.

Radiance Therapeutics is a funded company, having raised a total of $14M across 3 funding rounds to date.

Radiance Therapeutics was founded in 2018 in Oro Valley, United States, within the medical device sector focused on ophthalmology. A beta ophthalmic applicator is being developed to manage glaucoma surgically by down-regulating Tenons capsule fibroblasts. Topical beta therapy is applied to sites of trabeculectomy and drainage device implantation. Operations center on device innovation for improved surgical outcomes in eye care.

Radiance Therapeutics's top competitors include ViaLase, ELIOS Vision and BELKIN Vision.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available